An Acupuncture Study for Breast Cancer Survivors With Joint Pain on Hormonal Therapies

Description

The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for breast cancer survivors with joint pain on hormonal therapies.

Conditions

Breast Cancer, Breast Cancer Female, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Breast Cancer Stage IIIB, Breast Cancer Stage IIIc, Breast Cancer, Male

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for breast cancer survivors with joint pain on hormonal therapies.

Researching the Implementation of Acupuncture for Aromatase Inhibitor-related Arthralgias in Diverse Underserved Breast Cancer Survivors (ReIMAGINE)

An Acupuncture Study for Breast Cancer Survivors With Joint Pain on Hormonal Therapies

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

New York

Memorial Sloan Kettering Cancer Center (All protocol activites), New York, New York, United States, 10065

Richmond Hill

Jamaica Hospital Medical Center, Richmond Hill, New York, United States, 11418

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * English- or Spanish-speaking
  • * Black and/or Hispanic women with a history of stage I, II, or III BC (transgender males are eligible to enroll)
  • * No evidence of current BC disease
  • * Receiving AI for at least 28 days with plan to continue for another 14 weeks
  • * Worst pain rated ≥4 on a 0-10 scale in the preceding week
  • * ≥15 days with pain in the past 30 days
  • * Pain lasting ≥1 month
  • * Pain attributed to AI as reported by the patient
  • * Willing and able to complete questionnaires and other study activities
  • * Willing and able to provide informed consent for the trial
  • * All Stage IV Cancer
  • * Active oncological disease
  • * Completed chemotherapy, surgery, or radiation \<4 weeks prior to study
  • * Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout)
  • * Procedures involving affected joints within the last month or planned in the next 14 weeks
  • * Prior acupuncture use for pain
  • * Implanted electronic device (e.g., pacemaker)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Memorial Sloan Kettering Cancer Center,

Kevin Liou, MD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

2028-06-30